UCB is a biopharmaceutical company based in Belgium that researches and develops medicines for people with severe diseases of the nervous system and immune system. Its products include treatments for epilepsy, Parkinson's disease and other neurological conditions, along with biologic therapies used in immunology and inflammatory disorders. The company serves patients and healthcare professionals through its own commercial operations in many countries and through partnerships, and it also conducts research aimed at bringing new therapies from its laboratories to clinical use.
The shares are listed on the Euronext Brussels in Belgium under the code UCB, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #47 of 111 on the Euronext Brussels · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Belgium yet.
TrendFair
61/100
Mixed trend against its averages.
See the numbers →
Above 200-day average7.5%
From 52-week high-9.2%
MomentumFair
65/100
Typical recent returns for this exchange.
See the numbers →
3-month return6.5%
6-month return7.1%
12-month, skipping last month-12.5%
Stability (higher is calmer)Weak
35/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)39.4%
Worst drawdown, 1 year (smaller is calmer)-30.3%
LiquidityStrong
98/100
Trades actively.
See the numbers →
Avg daily value traded55.30M EUR
Zero-volume days0.0%
IncomeWeak
27/100
Dividend is small or irregular.
See the numbers →
Dividend yield0.4%
Years with dividends5
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Belgium when fundamentals data for this market is added. All Belgium stocks.
52-wk range 197.45 – 289.50Daily closes, split-adjusted
Signals
50-day average211.61
200-day average241.12
Golden/death cross (60d)Death, 52 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)8.97
Technical summary
Daily
Bullish
12 bullish · 0 neutral · 4 bearish
Weekly
Strongly bullish
10 bullish · 1 neutral · 1 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
211.4
Bullish
EMA 10
217.2
Bullish
SMA 20
208.4
Bullish
EMA 20
212.2
Bullish
SMA 50
211.6
Bullish
EMA 50
214.6
Bullish
SMA 100
228.5
Bullish
EMA 100
222.9
Bullish
SMA 200
241.1
Bullish
EMA 200
227.9
Bullish
Oscillators (daily)
RSI (14)
77.54
Bearish
MACD (12, 26)
3.66
Bullish
Momentum (12)
28.08
Bullish
Stochastic %K (14)
98.25
Bearish
Williams %R (14)
-1.75
Bearish
CCI (20)
405.7
Bearish
Pivot points (classic, last session)
S3
209.3
S2
219.7
S1
239.4
Pivot
249.8
R1
269.5
R2
279.9
R3
299.6
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
1.02 EUR
Yield on today's price
0.39%
Frequency
Annual
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
1.0150
0.9730
0.9520
0.9310
0.9100
0.8890
0.8680
0.8470
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
